Prospective observational study to assess the long term safety profile of venetoclax in a Swedish cohort of Chronic Lymphocytic Leukaemia (CLL) patients

12/06/2017
15/12/2025
EU PAS number:
EUPAS19010
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

p16-562-protocol-pmos-v3_redacted

English (3.1 MB - PDF) View document
Updated protocol

p16562-protocol-pmos-v6_Redacted.pdf

First published: 03/05/2024
English (1.95 MB - PDF) View document
Study results
Study report
Other information